February 17, 2022 Clinical Research Small study that suggests good looks portends a better functioning immune system ignores cultural determination of attractiveness, normal immune system variability, and cannot demonstrate causality among its other limitations. + it’s as judgmental as hell.
February 14, 2022 Clinical Research FDA stops the review of the incomplete data (two-dose COVID vaccine for children 0-5 years-old) it asked from Pfizer. Why did you ask for it in the first place? Says now it will wait for the complete three-dose data set. What a surprise.🙄
January 18, 2022 Clinical Research Preprint study tests their hypothesis behind a possible mechanism behind Long-Covid cognitive deficits. It seems to mimic what is seen with certain chemotherapy regimens that affect the brain.
January 14, 2022 Clinical Research New evidence strongly suggests Epstein-Barr virus (EBV) may help trigger Multiple Sclerosis. Opens the door to further investigation of the mechanism of the disease and if corroborated, lead to vaccines to prevent EBV infection.
December 23, 2021 Clinical Research New Ottawa Public Health self-isolation requirements are based on lack of COVID testing tools. Understandable, but for most, not practical. And, “The One Vaccine to Rule Them All” is a phase 1 study. Let’s not get ahead of ourselves.
December 16, 2021 Clinical Research Although bronchial lung tissue culture study showed Omicron grew 70x faster than Delta, it cannot be extrapolated to potential clinical outcomes. Lagging clinical indicators will arrive shortly to answer questions pertaining to severity of illness.
December 8, 2021 Clinical Research Initial Omicron data released. Small study from South Africa. Pfizer jumps in with theirs today. Many questions about clinical efficacy remain. Answers will come soon.
November 30, 2021 Bioengineering Kinematic-replicating xenobots constructed from frog embryonic cells. A fascinating window into how organizing cells in a specific configuration leads to a replicative behaviour not seen in cells or organisms.
November 17, 2021 Clinical Research Moderna submits data to Health Canada for approval of its COVID-19 vaccine for children. Expect approval within weeks. I review with @billcarrolltalk why the dose is one-half of the adult version. #VaccinesWork
November 4, 2021 Clinical Research AstraZeneca applies for approval of antibody treatment that provides passive immunity against COVID-19 for up to a year according to the press release. Indicated for vulnerable people who are immunocompromised or who have not responded to the vaccine.
